Nisa Investment Advisors LLC Invests $1.17 Million in Astera Labs, Inc. $ALAB

Nisa Investment Advisors LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 5,975 shares of the company’s stock, valued at approximately $1,170,000.

Several other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after buying an additional 2,751,747 shares in the last quarter. State Street Corp raised its position in shares of Astera Labs by 39.3% during the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after acquiring an additional 604,363 shares during the last quarter. 1832 Asset Management L.P. lifted its stake in shares of Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after acquiring an additional 929,600 shares during the period. Geode Capital Management LLC boosted its holdings in Astera Labs by 36.2% in the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock valued at $112,562,000 after acquiring an additional 330,841 shares during the last quarter. Finally, FengHe Fund Management Pte. Ltd. bought a new position in Astera Labs in the second quarter valued at about $106,772,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $172.14 on Thursday. The firm has a market capitalization of $29.08 billion, a price-to-earnings ratio of 155.08, a PEG ratio of 2.46 and a beta of 1.50. The company’s 50 day simple moving average is $159.24 and its 200 day simple moving average is $165.05. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business’s revenue for the quarter was up 103.9% compared to the same quarter last year. During the same period last year, the business posted $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the transaction, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at approximately $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 576,936 shares of company stock worth $87,409,540 in the last three months. 12.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ALAB shares. TD Cowen dropped their price objective on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. BNP Paribas Exane began coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating and a $225.00 price objective on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $190.11.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.